Skip to main content
. 2014 Oct 27;2014:864237. doi: 10.1155/2014/864237

Table 5.

Indices indicative of both hemodynamic (systolic blood pressure, SBP) and oxygenation (tissue oxygen tension, TO2) recovery1 following the administration of either the placebo (LRS) or the test article (OC99): time to recovery (TtR) and duration of recovery (DoR).

Group†,‡ tPO2 (>10 mmHg) SBP (>90 mmHg)
TtR (min) DoR (min) %2 TtR (min) DoR (min) %2
HEX + CTRL 50.0 (19.1) 56.7 (27.0) 2/6 26.7 (4.2) 136.7 (15.8) 2/6
HEX + LOW 35.0 (9.6) 76.7 (26.0) 4/6 23.3 (3.3) 150.0 (13.4) 6/6
HEX + MID 33.3 (6.7) 150.0 (19.1)∗ 6/6 20.0 (0.0) 170.0 (10.0) 6/6
HEX + HIGH 23.3 (3.3) 176.7 (3.3)∗ 6/6 20.0 (0.0) 180.0 (0.0)∗ 6/6
P-value 0.8415 0.0005 0.4402 0.0178

Data are mean values (standard error of the mean).

1For the purposes of this study, “oxygenation” and “hemodynamic” recovery were defined as the time point(s) when the tissue (intestinal) oxygen tension (TO2) and the systemic (systolic) blood pressure (SBP) (resp.) reached values associated with sustainable normal physiological function (TO2 > 10 mmHg, SBP > 90 mmHg).

2The ratio of the number of animals that reached the set threshold level. For the TO2 parameter, there were 2 animals from the HEX + LRS group and 2 animals from the HEX + LOW group that did not reach the set threshold level.

Treatments delivered via continuous IV infusion over 60 min at 10 mL/kg/hr (combined) in the setting of fluid-resuscitation (20 mL/kg at 20 mL/kg/hr) with either Hextend (HEX+) or LRS (LRS+); end of dosing (DOSEEND) is time zero (t = 0 hr), while END is the mean value readings taken 2 hours after dosing (140, 160, and 180 min).

LRS (n = 6): 10 mL/kg of LRS; LOW (n = 6): 1 mL/kg of OC99 + 9 mL/kg of LRS; MID (n = 6): 5 mL/kg of OC99 + 5 mL/kg of LRS; HIGH (n = 6): 10 mL/kg of OC99.

* P < 0.05 (adjusted) versus HEX + LRS.